Company: SPEG
Filing Date: 2025-01-21
Form Type: CORRESP
Source: 0001213900-25-005100
Chunk: 3

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-01-21
Form: CORRESP
Chunk 3
---
 comment. Please see the revised Cover Page of the S-1, and pages 24, 145 and 184.

7. When discussing the class B ordinary shares, please revise to clarify that the class B ordinary shares will have the right to vote on the appointment or removal of directors.

Response: The Company revised the disclosure in the S-1 to address the Staff’s comment. Please see the revised Cover Page of the S-1.

8. Please revise the cross-reference relating to dilution to include all the sections of the prospectus for disclosures related to dilution. See Item 1602(a)(4) of Regulation S-K.

Response: The Company revised
the disclosure in the S-1 to address the Staff’s comment. Please see revised Cover Page of the S-1.

Prospectus Summary, page 1

9. Please disclose in tabular format the nature and amount of the compensation received or to be received by your sponsor, its affiliates, and promoters, the amount of securities issued or to be issued by you to the sponsor, its affiliates, and promoters and the price paid or to be paid for such securities, and, outside of the table, the extent to which this compensation and securities issuance may result in a material dilution of the purchasers’ equity interests, as required by Item 1602(b)(6) of Regulation S-K.

Response: The Company revised
the disclosure in the S-1 to address the Staff’s comment. Please see page 3 of the S-1.

Management Team, page 3

10. When discussing Mr. Johnston’s involvement with KINS Technology, which is now CXApp Inc., please disclose the current market price and the level of redemptions.

Response: The Company revised
the disclosure in the S-1 to address the Staff’s comment. Please see pages 8, 103, 130 and 136 of the S-1.

Initial Business Combination, page 5

11. Please disclose your plans if you do not consummate a de-SPAC transaction within 24 months, including whether you expect to extend the time period, whether there are any limitations on the number of extensions, including the number of times, and the consequences to the SPAC sponsor of not completing an extension of this time period. See Item 1602(b)(4) of Regulation S-K.

Response: The Company revised
the disclosure in the S-1 to address the Staff’s comment. Please see page 11 of the S-1